🔗 Share this article

Chancellor Reeves has revealed she is preparing "targeted steps to address household expense pressures" in next month's financial statement.

Speaking to the BBC, she emphasized that lowering inflation is a collective task of both the administration and the central bank.

The UK's price growth is forecast to be the most elevated among the Group of Seven developed nations this calendar year and the following year.

Potential Utility Cost Interventions

Sources suggest the administration could intervene to reduce utility costs, for instance by reducing the current 5% rate of value-added tax charged on energy supplies.

A further approach is to cut some of the government charges presently included in household expenses.

Budgetary Limitations and Analyst Predictions

The administration will obtain the latest assessment from the official forecaster, the OBR, on Monday, which will clarify how much space there is for these measures.

The view from most analysts is that the Chancellor will have to announce higher taxes or spending cuts in order to adhere to her declared borrowing rules.

Previously on Thursday, estimates showed there was a £22 billion gap for the Treasury chief to resolve, which is at the lower end of expectations.

"It is a collective job between the central bank and the government to bear down further on some of the sources of inflation," Reeves informed the BBC in the US capital, at the conferences of the IMF and World Bank.

Tax Pledges and Global Concerns

While much of the focus has been on likely tax increases, the chancellor said the latest information from the OBR had not altered her commitment to campaign commitments not to raise rates on income tax, VAT or National Insurance.

She attributed an "unpredictable world" with growing international and commercial issues for the Budget revenue measures, probably to be directed on those "with the broadest shoulders."

International Economic Tensions

Referring to concerns about the UK's trade ties with the Asian nation she said: "Our national security invariably come first."

Last week's declaration by Chinese authorities to increase export controls on critical minerals and other resources that are key for advanced tech production led US President the US President to suggest an extra 100% tariff on goods from the Asian country, raising the possibility of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary called the Chinese move "commercial pressure" and "a global supply chain power grab."

Inquired about considering the US offer to participate in its battle with the Asian nation, the Chancellor said she was "very concerned" by Chinese measures and urged the Beijing authorities "not to put up barriers and restrict access."

She said the move was "harmful for the international commerce and creates additional challenges."

"I believe there are sectors where we must challenge China, but there are also valuable opportunities to trade with Chinese markets, including banking sector and other areas of the economy. We've got to get that balance appropriate."

The chancellor also affirmed she was collaborating with G7 counterparts "on our own essential resources strategy, so that we are more independent."

Health Service Drug Pricing and Investment

Reeves also admitted that the price the National Health Service pays for pharmaceuticals could rise as a consequence of ongoing discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and capital.

Some of the biggest global drug companies have said in recent statements that they are either pausing or canceling projects in the United Kingdom, with several blaming the low prices they are getting.

Last month, the government science advisor said the cost the health service spends on drugs would need to rise to stop firms and pharmaceutical investment leaving the United Kingdom.

The Chancellor informed the BBC: "We have seen due to the cost structure, that clinical trials, innovative medicines have not been provided in the United Kingdom in the way that they are in other European countries."

"The objective is to guarantee that people getting care from the NHS are able to receive the finest critical drugs in the world. And so we are reviewing these issues, and... looking to obtain more capital into Britain."